Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autoimmune disease causing a wide spectrum of autoimmune dysfunction potentially including diabetes of an autoimmune etiology. We have previously described a pair of discordant APECED siblings and pointed to a possible role of 5 0 insulin variable number of tandem repeats (VNTR) locus IDDM2 in the appearance of diabetes within this disease. In vitro studies have previously suggested that class I VNTR alleles were associated with decreased fetal thymic insulin expression. We genotyped the 5 0 INS VNTR locus and several flanking 11p15.5 markers in 50 Finnish APECED subjects and explored the possible contribution of IDDM2 in the development of diabetes. The shorter 5 0 INS VNTR class I alleles (o35 repeats) were more prevalent in the diabetic Finnish APECED subjects than in non-diabetic APECED subjects. Logistic regression analysis revealed that having 1 short (o35) VNTR allele did not increase the risk of developing diabetes (95% CI 0.6-27.0), whereas having 2 short alleles conferred a 43.5-fold increased risk (95% CI 3.0-634.6). We conclude that short 5 0 INS VNTR class I alleles play a role in susceptibility to autoimmune diabetes in the context of APECED.
Introduction
Autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy (APECED) or autoimmune polyglandular disease type 1 (APS1) is a severe but rare organ-specific autoimmune disease, with defective cell-mediated immunity and a monogenic autosomal recessive mode of inheritance. Its prevalence depends on ethnic origin and is 1:25 000 in the Finnish population. 1 The most common clinical features of APECED are chronic mucocutaneous candidiasis, hypoparathyroidism and Addison's disease. Other manifestations may also occur variably and include hypogonadism, hypothyroidism, alopecia, malabsorption, hepatitis, juvenile-onset pernicious anemia and auto-immune diabetes.
2-4 APECED cases with diabetes have been more often found in the Finnish population than in any other ethnic groups. 5 This multisystem disease has been linked to a single gene defect in AIRE (autoimmune regulator). 6 Because APECED is phenotypically and genetically highly heterogeneous, genotype-phenotype correlations have been difficult to ascertain. 5 Even within the same family, affected siblings may show remarkable variations in disease severity and clinical signs. The only phenotype-genotype association reported to date in APECED is the higher prevalence of candidiasis in subjects with AIRE mutation R257X. 7 This clinical complexity, even for a monogenic disease, is believed to be due to the effects of other genes and/or to complex interactions between environmental and genetic factors.
Multiple type I diabetes (T1D) susceptibility loci have been reported. The most important of these, IDDM1, has been mapped within the major histocompatibility complex (MHC) class II, region located on chromosome 6p21.31.
8 Interestingly, protective alleles described for T1D (DRB1*15 and DQB1*0602) appeared similarly protective in the APECED subjects. [7] [8] [9] Furthermore, Addison's disease has been positively associated with the HLA DRB1*03 allele, and alopecia with both HLA DRB1*04 and HLA DQB1*0302 alleles. Association of susceptibility alleles to diabetes risk in the context of APECED seems to be controlled by other more important genetic factors.
IDDM2, another T1D susceptibility locus, has been mapped within the upstream region of the insulin gene (INS) corresponding to a minisatellite polymorphism of a variable number of tandem repeats (VNTR), located on human chromosome 11p15.5 ( Figure 1 ). In Caucasians, the 5 0 INS VNTR has been divided into three distinct classes of alleles according to the number of repeats. 10 The class I alleles are associated with susceptibility to T1D (odds ratio (OR) 1.9-5.0) in a recessive fashion, whereas class III alleles are associated with dominant protection. 7, 11, 12 This minisatellite has also been shown to have effects on transcription of INS 13, 14 and IGF2. 15 The participation of other functional polymorphisms in linkage disequilibrium with the 5 0 INS VNTR has recently been evaluated, particularly a -23HphI A/T (single nucleotide polymorphisms) SNP which gives rise to an insulin pre-mRNA splicing variant. 16, 17 We hypothesized in a previous study of APECED siblings that IDDM2 contributes to the development of diabetes; 18 such an association in a limited number of British subjects with APECED was recently reported. 19 We now confirm their finding in a larger cohort of Finnish APECED subjects with confirmed AIRE mutations as well as in an additional pair of siblings with APECED who are discordant for diabetes. We also report a higher proportion of small class I 5 0 INS VNTR alleles (fewer than 35 repeats) in the Finnish APECED subjects with diabetes and review other potential diabetes predisposing loci such as specific alleles of the tyrosine hydroxylase tetranucleotide repeat minisatellite, HUMTH01.
Results
Siblings with APECED who are discordant for diabetes In order to test our hypothesis concerning the contribution of IDDM2 to diabetes susceptibility in APECED, we identified another pair of siblings discordant for diabetes and of Moroccan origin. As with our French Canadian family, 18 the patient with diabetes was homozygous for the class I 5 0 INS VNTR, and the non-diabetic sibling was heterozygous for the class I and the dominantly protective class III allele. This prompted us to examine the contribution of IDDM2 to diabetes risk in a large cohort of Finnish subjects with APECED (n ¼ 8 diabetic subjects, 42 non-diabetic subjects). The proportion of diabetic subjects in our cohort (16%) is in accordance with the reported frequency of this disease component in the Finnish APECED patients of similar ages. While the comparison between the number of Finnish diabetic versus non-diabetic subjects carrying the class I/I genotype showed only a trend towards significance (P ¼ 0.132), the increase of sample size by including our non-Finnish diabetic subjects suggested that homozygosity for class I 5 0 INS VNTR alleles was associated with an increased risk of developing diabetes (P ¼ 0.049). Furthermore, when the reported UK subjects with APECED 19 were pooled with our Finnish cohort, the association was clearly significant (P ¼ 0.019; n ¼ 16 APECED with diabetes; n ¼ 67 APECED no diabetes; n ¼ 46 class I/I; n ¼ 37 class I/III and III/III); and the OR of developing diabetes when possessing a I/I genotype was 4.5 (CI ¼ 1.2-17.1).
Closer examination of class I allele frequency distribution relative to the number of repeats is shown in Figure 2 for our Finnish subjects with a I/I genotype. The majority of the diabetic subjects had shorter class I 5 0 INS VNTR alleles, and 9 out of 14 alleles contained fewer than 35 repeats. In contrast, for the non-diabetic APECED subjects, only 13 out of 64 alleles contained fewer than 35 repeats, a proportion significantly different from that seen in the diabetic subjects (Fisher's Exact Test, P ¼ 0.002; OR ¼ 7.1 with 95% CI of 2.0-24.7). By logistic regression analysis, having 1 short (o35) VNTR allele, did not increase the risk of developing diabetes (95% CI 0.6-27.0), whereas having 2 short alleles conferred a 43.5-fold increased risk (95% CI 3.0-634.6).
Other ch11p15.5 markers and linkage analysis
We next genotyped the diabetic subjects for markers located on a 35 kb region of ch11p15.5. spanning the HUMTH01 locus and up to IGF2 ApaI in exon 9 ( Table 2) . Five linkage disequilibrium (LD) blocks are included in this region (Barratt et al. 20 and Figure 1 ). To test whether polymorphic variation of flanking loci influenced the impact of IDDM2 on diabetes risk, Stead et al. used the minisatellite variant repeat mapping technique to define five classes of 5 0 INS VNTR within a mixed North American and European population. They described two highly divergent class III lineages, IIIA and IIIB (corresponding to protective haplotype, PH, and very protective haplotype, VPH, respectively), and three class I lineages termed IC þ , ID þ and IDÀ. The class I lineages were defined by a combination of variant repeat distribution (IC: o38 repeats; ID X38 repeats) and flanking haplotypes. Almost, all class I haplotypes correspond to allele þ of the þ 3580MspI SNP, located within intron 1 of IGF2, except for a subset of ID alleles termed ID-. The five 5 0 INS VNTR lineages were shown to be in linkage disequilibrium with specific alleles of HUMTH01. 21 We therefore, analyzed genotypes of the 21 However, differences in the distribution of HUMTH01 allele frequencies were observed in Finnish subjects with APECED compared to the general Finnish population 22 and when analyses were corrected for multiple comparisons, allele 9 showed a trend towards over-representation in the diabetic versus non-diabetic APECED subjects (P ¼ 0.08, OR ¼ 4.9 with 95% CI ¼ 1.56-15.13). This supports our finding with regards to the role of class I 5 0 INS VNTR in the predisposition to diabetes in APECED subjects, and while it is in linkage disequilibrium with the 5 0 INS VNTR, it also raises questions as to a potential role for this TH allelic variant, since tyrosine hydroxylase is a known autoantigen in APECED (see Discussion).
Impact of HLA genotype on INS VNTR and association with diabetes Only 8 out of 41 APECED subjects for whom HLA typing was available had at least one HLA protective allele DQB1*0602 and none of our diabetic subjects possessed this allele. The relatively small size of our cohort did not allow us to confirm the association of this allele with protection from APECED-associated diabetes as reported by Gylling et al.
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Discussion
We previously reported a French Canadian family in which two APECED affected siblings with the same AIRE mutations were discordant for diabetes; 18 the affected sibling possessed a 5 0 INS VNTR I/I genotype and the unaffected sibling, a I/III genotype, potentially implicating this locus in the development of APECED-associated 
Determination of sublineages of class I alleles: + refers to IC+ or ID+ and À refers to IDÀ. VNTR alleles association to autoimmune diabetes J Paquette et al diabetes. A second pair of siblings from Morocco, also discordant for diabetes, had genotypes consistent with this hypothesis (Table 3 ). This motivated us to genotype a large Finnish cohort to examine the contribution of this locus to diabetes risk.
(Z-
The Finnish population has been shown to have the highest frequency of the 5 0 INS VNTR class I/I diabetespredisposing genotype at the IDDM2 locus, compared with other populations reported, as summarized in Table 3 , and it is of note that the incidence of T1D in Finland is the highest in the world. 24 The present study has revealed that in APECED subjects, homozygosity for the 5 0 INS VNTR class I (susceptibility) alleles is even more frequent in those who are diabetic compared to those who have not become diabetic. Diabetics had significant autoantibody titers to several antigens tested, although titers were not predictive of the presence of diabetes (IA2: 1/8 diabetics (DM), 1/42 no DM; GAD: 2/8 DM, 13/42 no DM; TH: 3/8 DM, 17/42 no DM; AADC 4/8 DM, 33/42 no DM). Compared to autoantibody associations already examined in APECED patients with diabetes, 25 the VNTR genotype has a much higher positive predictive value particularly if class I allele size is examined.
These observations extend the findings of Adamson et al., who reported a high proportion of class I/I genotype in a smaller cohort (n ¼ 33) of APECED subjects from the UK. 19 This UK cohort comprised an unusually high proportion of diabetic subjects (24%) which might have biased the statistical analysis. While their study and ours both suffer from relatively small sample sizes owing to the rarity of mutation-confirmed, diabetic APECED subjects and non-diabetic APECED subjects with comparative ages, our study has confirmed and refined the role of the class I VNTR in diabetes susceptibility. Interestingly, a correlation with the repeat number of the class I alleles, with the smaller alleles being more predisposing than larger class I alleles was found.
The 42 repeat class I allele (allele 814) has been reported to be the most common class I allele, accounting for 25% of all transmissions. 26 We did have parental DNA for the French-Canadian diabetic and non-diabetic siblings. The diabetic child possessed a 43 repeat allele of paternal origin and a maternal 42 repeat allele, increasing the likelihood of it behaving as a susceptibility allele. The mechanisms underlying the protective behavior of this 42 repeat class I allele are as yet unknown, although all protective ID-alleles have a specific variant repeat within the insulin minisatellite characterized by the presence of an A B A repeat motif (detailed in Stead et al.
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Tyrosine hydroxylase (TH) is a known autoantigen in APECED, and association studies for autoantibody consistency and disease component were strongest for alopecia. 27 However, we could not find any associations between TH autoantibody titers and alopecia, or between specific HUMTH01 alleles and TH autoantibody titers in our Finnish APECED cohort, possibly owing to the time lapse between alopecia onset and TH autoantibody titre determination. The HUMTH01 allele frequencies reported in our study (data not shown), however, diverged from those of a Finnish non-APECED population. 22 We observed a trend towards a higher frequency of HUMTH01 allele 9 (Z-4), in linkage disequilibrium with small class I INS VNTR alleles (predisposing to T1D, class ID-alleles), and a lower frequency of the allele 10-1 (Z-1), in linkage disequilibrium with the class III INS VNTR alleles. 21 Significant differences in these allele frequencies were noted between our APECED subjects with and without diabetes. This suggests a novel association of allele 9 of HUMTH01 with APECED.
Tyrosine hydroxylase is expressed primarily in the central nervous system, as well as in neuropeptidergic neurons within the pancreas 28 and in the iridal nerves reinnervating the pancreatic grafts. 29 A functional role for HUMTH01 allelic variants in differential transcriptional regulation has also been suggested, which further implicates this locus in the pathophysiology of disease components in APECED. 22 It is of note, nevertheless, that in the T1D (non-APECED) population mapping studies of Barratt et al., the HUMTH01 allele 9 did not confer additional risk if added to the effect of the -23 INS HphI marker. 20 Unfortunately, APECED population sample sizes available for refined haplotype studies at this locus are too small for us to confirm an additive effect of the HUMTH01 locus and IDDM2; although as more APECED cohorts are genotyped, pooled data analyses may shed light on these questions.
Since the HLA class II locus (IDDM1) is an important locus for T1D susceptibility whose underlying mechanism is well-understood, 30 others have looked for allelic associations with diabetes in the context of APECED. 21 Although no susceptibility alleles were identified, a protective haplotype was described. None of the 6 diabetic patients for whom HLA typing was available, possessed the HLA class II protective allele (DRB1*15-DQB1*0602).
In conclusion, this study adds evidence that loss of function of the AIRE protein is not the only locus involved in the development of insulin dependent diabetes mellitus in individuals with APECED. From a VNTR alleles association to autoimmune diabetes J Paquette et al mechanistic point of view, synergy between the decreased expression of insulin by the fetal thymus that is observed when both a short 5 0 INS VNTR and mutant AIRE protein are present may tip the balance towards development of diabetes. We confirm the relevance of the 5 0 INS VNTR, and postulate that HUMTH01, may also contribute to the development of this disease component. It is hoped that this and future genetic studies will help clinicians to predict the clinical course of subjects with APECED better, and thus, to counsel, treat and eventually prevent better some of the more debilitating disease components such as diabetes.
Patients and methods
Patients and study design DNA was obtained following informed consent from peripheral blood leukocytes of 50 APECED subjects from Finland (27 women and 23 men). Ages of the subjects ranged between 5.2 and 54.3 y (median age ¼ 29.0 y). The subjects were members of 46 unrelated families and also included 2 pairs of siblings. 78.0% of the subjects were homozygous for the commonest Finnish AIRE mutation (R257X), 18.0% of the subjects were compound heterozygotes (R257X mutation and primarily the 13 bp deletion in exon 8 (967-979del13bp or C322fsX372) and in one patient with clinically evident APECED, no mutation was found. Two pairs of APECED siblings discordant for diabetes from Canada and Morocco were also included; the former pair of female siblings was described in Ward et al. and are now 23 y (with diabetes) and 20 y (non-diabetic). 18 The latter pair was a 20 yearold diabetic patient and his 13.8 year-old brother found to be homozygous for the 1193delC mutation (P398fsX478).
This was a blinded retrospective study; clinical information about the subjects, including all autoimmune disease components, was only obtained after the genotyping of the IDDM2 locus and several adjacent polymorphisms was complete.
Autoantigen determination
Autoantigens (anti-GAD, anti-IA2. anti-TH and anti-AADC) were determined as previously described. 21 All patient and control sera were run in triplicate; normal upper levels for autoantibodies were calculated as the mean þ 3 s.d. for healthy blood donors.
Genotyping
The reader is referred to Figure 1 for the location of the single nucleotide polymorphisms (SNPs) and minisatellite markers used in this study.
-23HphI. To determine the 5 0 INS VNTR classes I (diabetes susceptibility) and III (dominant protection from diabetes) genotypes, we first genotyped a surrogate marker in tight linkage disequilibrium with the VNTR: the -23HphI site relative to INS translation start site (SNP database id: rs689)
The presence of HphI restriction enzyme site, ('A' allele, þ ) is in complete linkage disequilibrium with the class I alleles of the 5 0 INS VNTR, and its absence ('T' allele, -) is linked to class III alleles. 20, 31 The PCR reaction mix was as described in. 8 IGF2 exon 9 ApaI and intron 1 MspI RFLP. The primers, cycling conditions and analysis of the ApaI polymorphism (NCBI SNP database; rs680) were as described in. 16 The intron 1 polymorphism locus was amplified with primers specified in 21 in 1 Â Taq DNA polymerase buffer supplemented with 1 mM MgCl 2, 5% dimethylsulfoxide (DMSO) using an annealing temperature of 60 1C.
HUMTH01 microsatellite typing. The HUMTH01 (TCAT) n locus lies within intron 1 of the TH gene and is composed of alleles of 6-10 tetramer repeats. This locus was amplified using primer sequences as described 32 in a reaction which included 50 ng of genomic DNA, 1 mM of each primer, 1 Â Taq DNA polymerase buffer supplemented with 1 mM MgCl 2, 5% dimethylsulfoxide (DMSO), 25 mM dCTP, dGTP and dTTP, 15 mM dATP, 1 mCi of [a 32 P]dATP 3000 Ci/mmol (Amersham Biosciences Corp., Baie d'Urfé, QC, Canada) and 0.8 U of Taq DNA polymerase (Invitrogen Corporation). The cycling parameters were as followed: an initial denaturation at 94 1C for 2 min, followed by 30 cycles of 94 1C for 30 s, 69 1C for 30 s. and 72 1C for 30 s. An allelic ladder was obtained by mixing the PCR products from three heterozygous control individuals, containing alleles 6, 7, 8, 9 and 10-1. The 10-1 allele represents 10 repeats minus one nucleotide. Also, M13mp18 sequencing ladder was used to determine allelic sizes, allowing determination of allelic frequencies and comparison with other reports. 25, 26 The alleles were resolved on a 6% denaturing polyacrylamide gel (19:1 acrylamide:bis) and detected by autoradiography of the vacuum dried gel.
HLA genotyping. The HLA class II DQA1, DQB1 and DRB1 genes were previously typed for 41 of the Finnish subjects included in this study as reported by Gylling et al. 23 
